1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study on the Treatment of Differentiated Thyroid Carcinoma with AnlotinibDTC - Differentiated Thyroid CancerActive, not recruitingPhase 22024-11-07NCT05007093